会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明专利
    • Novel antibiotic pa-39504-x3 and its preparation
    • 新型抗生素PA-39504-X3及其制备方法
    • JPS5740485A
    • 1982-03-06
    • JP11718280
    • 1980-08-25
    • Shionogi & Co Ltd
    • TANAKA KENTAROUKONDOU EIJIMATSUMOTO KOUICHISHIYOUJI JIYUNICHITSUJI NAOKI
    • C07D477/00A61K31/397A61K31/40A61P31/04C07D477/20C12P17/18C12R1/465
    • C07D477/20C12P17/184
    • NEW MATERIAL:An antibiotic PA-39504-X
      3 expressed by the formula and a pharmacologically acceptable salt thereof.
      USE: An antimicrobial agent, having an antimicrobial activity against Gram-positive and Gram-negative bacteria and inhibitory action on β-lactamase production, and administered orally or parenterally in a dose of 0.1W30g/day in the case of the subcutaneous administration.
      PROCESS: A strain, belonging to the genus Streptomyces, and having the ability to produce an antibiotic PA-39504-X
      3 , e.g. Streptomyces sp. PA-39504 (FERM-P No.5265), is cultivated in a liquid nutrient culture medium under aerobic conditions, and the antibiotic PA-39504-X
      3 is separated and collected from the resultant culture after the completion of the cultivation. Alternatively, the antibiotic PA- 39504-X
      3 can be obtained by refluxing an antibiotic PA-31088-IV in carbon tetrachloride with triphenylphosphine under mild conditions, and deoxidizing the reaction product.
      COPYRIGHT: (C)1982,JPO&Japio
    • 新材料:由下式表示的抗生素PA-39504-X3及其药理学上可接受的盐。 用途:具有抗革兰氏阳性和革兰氏阴性细菌的抗微生物活性和对β-内酰胺酶生产的抑制作用的抗微生物剂,并且在皮下给药的情况下以0.1-30g /天的剂量口服或肠胃外给药。 方法:属于链霉菌属的菌株,并具有生产抗生素PA-39504-X3的能力,例如, 链霉菌属 PA-39504(FERM-P No.5265)在有氧条件下在液体营养培养基中培养,培养完成后从所得培养物中分离收集抗生素PA-39504-X3。 或者,可以通过在温和条件下用三苯基膦在四氯化碳中回流抗生素PA-31088-IV并使反应产物脱氧来获得抗生素PA-39504-X3。
    • 3. 发明专利
    • Novel antibiotic pa-41746-d and its preparation
    • 新型抗生素PA-41746-D及其制备方法
    • JPS5939895A
    • 1984-03-05
    • JP14954482
    • 1982-08-27
    • Shionogi & Co Ltd
    • TANAKA KENTAROUKONDOU EIJIMATSUMOTO KOUICHITSUJI NAOKI
    • C07D477/00A61K31/397A61K31/40A61P31/04C07D487/04C12P1/06C12P17/18C12R1/465
    • NEW MATERIAL:A compound(salt) shown by the formula I , whose disodium salt having the following physical and chemical properties. Electrophoresis mobility of filter paper: 2.3(mobility of epithienamycin A is 1.0). C Nuclear magnetic resonance: deltappm 21.7q, 3.24t, 55.0d, 60,4d, 64,4d, 127.7s, 139.8s, 169.0s, and 179.4s. H Nuclear magnetic resonance: deltappm(J=Hz)0.72d(6.0),2.36d-d(16.5, 11.0), 2.59d-d (16.5, 9.0), 3,01d-d(10.0, 5.5), 3,63q-d(6.0, 10.0), and 3.78m. Infrared absorption spectrum: muKB maxcm 3435, 1755, 1615, 1395, 1220-1200, 1105, 1066, and 1039. Ultraviolet spectrum shown by the formula II. USE:An antibacterial agent. PROCESS:A bacterium (FERM-P 5964) belonging to the genus Streptomyces, capable of producing PA-41746-D, is inoculated into a medium, and a product is separated and collected to give a compound shown by the formula.
    • 新材料:由式I表示的化合物(盐),其二钠盐具有以下物理和化学性质。 滤纸的电泳迁移率:2.3(epithienamycin A的迁移率为1.0)。 13 C核磁共振:deltappm 21.7q,3.24t,55.0d,60,4d,64,4d,127.7s,139.8s,169.0s和179.4s。 1 H核磁共振:deltappm(J = Hz)0.72d(6.0),2.36dd(16.5,11.0),2.59dd(16.5,9.0),3.01d-d(10​​.0,5.5),3,63q -d(6.0,10.0)和3.78m。 红外吸收光谱:muKB maxcm -1,3345,1755,1615,1395,1220-1200,1105,1066和1039。式II所示的紫外光谱。 用途:抗菌剂。 方法:将能够产生PA-41746-D的属于链霉菌属的细菌(FERM-P 5964)接种到培养基中,分离收集产物,得到式所示的化合物。
    • 4. 发明专利
    • Novel antibiotic troposulfenin and its preparation
    • 新型抗生素血友病及其制备
    • JPS59205994A
    • 1984-11-21
    • JP8132683
    • 1983-05-09
    • Shionogi & Co Ltd
    • TANAKA KENTAROUKONDOU EIJIMATSUMOTO KOUICHIHATSUTORI MITSUOTSUJI NAOKI
    • C12P17/14A61K31/39A61P31/04C07D327/04C12N1/20
    • PURPOSE: To prepare novel antibiotic troposulfenin useful as a drug or an animal drug, having antifungal and antibacterial action, by cultivating a specific bacterium belonging to the genus Pseudomonas, separating and collecting troposulfenin from the culture.
      CONSTITUTION: A bacterium such as Pseudomonas troposulfenii sp.nov. (FERM-P 7042) belonging to the genus Pseudomonas, capable of producing novel antibiotic troposulfenin, is cultivated in a medium, and antibiotic froposulfenin shown by the formula I (R is H or CH
      3 ) is obtained by separating and collecting it from the prepared culture. Troposulfenin or troposulfenin S-methyl ether shown by the fomula II obtained by methylating it at a mercapto group of 8-position has antifungal and antibacterial actions, and is a novel antibiotic useful as a medicine and animal drug.
      COPYRIGHT: (C)1984,JPO&Japio
    • 目的:通过培养属于假单胞菌属的特异性细菌,从培养物中分离和收集妥布硫磺蛋白,制备用作药物或动物药物的新型抗生素亚甲基亚砜,具有抗真菌和抗菌作用。 构成:一种细菌,例如托氏假单胞菌(Pseudomonas troposulfenii sp.nov)。 在培养基中培养属于假单胞菌属(Pseudomonas)的属于假单胞菌属(FERM-P 7042)的化合物,通过从制备的化合物中分离收集式I(R为H或CH 3)所示的抗生素亚磷酸氢盐 文化。 由甲基化8位巯基所得到的聚丙烯亚磺酸盐或聚丙烯亚磺酸S-甲基醚具有抗真菌和抗菌作用,是用作药物和动物药物的新型抗生素。
    • 5. 发明专利
    • Antibiotic pa-41746-a2 and its preparation
    • 抗生素PA-41746-A2及其制备方法
    • JPS59205378A
    • 1984-11-20
    • JP8132583
    • 1983-05-09
    • Shionogi & Co Ltd
    • TANAKA KENTAROUKONDOU EIJIMATSUMOTO KOUICHITSUJI NAOKI
    • C07D477/00A61K31/397A61K31/40A61P31/04C07D487/04C12P17/18C12R1/465
    • NEW MATERIAL:Antibiotic PA-41746-A2 and its salt. USE:Having antibacterial effect on Gram-positive and Gram-negative bacteria, improved beta-lactamase inhibitory action, useful as a drug as an antibacterial agent, an animal drug, or a disinfectant. Being administred to mem and animals orally or parenterally. Usable as a tablet, capsule, or powder as oral administration, and injection, paint, suppository, etc. as parenteral administration. A dose is generally about 1/10 - about several times that of cephalothin. Also usable as a raw material for pluracidomycin A. PREPARATION:A bacterium belonging to the genus Streptomyces, capable of producing PA-41746-A2, is cultivated in a medium, and the titled compound is obtained from the prepared culture. The medium contains a carbon source, nitrogen source, inorganic salt, etc. as a rule, and the cultivation is carried out by a process commonly used in preparation of antibiotic. Preferably the pH of the medium is 5.5-8.5 and the culture temperature is about 20-40 deg.C.
    • 新材料:抗生素PA-41746-A2及其盐。 用途:对革兰氏阳性和革兰氏阴性菌具有抗菌作用,改善β-内酰胺酶抑制作用,作为抗菌剂,动物药物或消毒剂有用。 口服或肠胃外给予动物和动物。 可作为口服给药的片剂,胶囊或粉剂,以及作为肠胃外给药的注射剂,油漆剂,栓剂等。 剂量通常为头孢噻吩的约1/10至约几倍。 也可用作pluracidomycin A的原料A.制剂:将能够产生PA-41746-A2的属于链霉菌属的细菌培养在培养基中,从制备的培养物中获得标题化合物。 培养基通常含有碳源,氮源,无机盐等,并且通过制备抗生素常用的方法进行培养。 优选地,培养基的pH为5.5-8.5,培养温度为约20-40℃。